Table 2.
Antimicrobial resistance profile of Staphylococcal strains.
| Strain | Antibiotics | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BP | OXA | GM | LVX | ERY | CM | LNZ | DPC | TP | VA | TET | TGC | FOS | FA | RA | SXT | |
| MSSA | >0.25 | 0.5 | ≤0.5 | ≤0.12 | 1 | 0.25 | 2 | 0.25 | ≤0.5 | 1 | ≤1 | ≤0.12 | ≤8 | ≤0.5 | ≤0.03 | ≤10 |
| MRSA | >0.25 | >2 | >8 | >4 | >4 | >2 | 2 | 1 | 4 | 2 | 2 | 0.5 | >64 | ≤0.5 | ≤0.03 | ≤10 |
| MSSE | – | ≤0.25 | ≤0.5 | ≤0.12 | 1 | 0.25 | 2 | 0.5 | 8 | 1 | ≤1 | ≤0.12 | ≤8 | ≤0.5 | ≤0.03 | ≤10 |
| MRSE | – | >2 | ≤0.5 | ≤0.12 | >4 | 0.25 | 2 | 0.25 | 1 | 1 | >8 | ≤0.12 | >64 | ≤0.5 | ≤0.03 | ≤10 |
BP, benzylpenicillin; OXA, oxacillin; GM, gentamicin; ERY, erythromycin; CM, clindamycin; LNZ, linezolid; DPC, daptomycin; TP, teicoplanin; VA, vancomycin; TET, tetracycline; TGC, tigecycline; FA, fusidic acid; RA, rifampin; SXT, trimethoprim/sulfamethoxazole.
Data are reported as μg/ml.